The Possible Association between IVF and Breast Cancer Incidence

详细信息    查看全文

• 作者：I. Pappo MD (1) (2)
  L. Lerner-Geva MD PhD (3)
  A. Halevy MD (2)
  L. Olmer MSc (4)
  S. Friedler MD (5)
  A. Raziel MD (5)
  M. Schachter MD (5)
  R. Ron-El MD (5)
  
• 关键词：Breast cancer ; In ; vitro fertilization ; Ovulation induction
• 刊名：Annals of Surgical Oncology
• 出版年：2008
• 出版时间：April 2008
• 年：2008
• 卷：15
• 期：4
• 页码：1048-1055
• 全文大小：198KB
• 参考文献：1. Lipworth L. Epidemiology of breast cancer. Eur J Cancer Prev 1995;4:7-0 CrossRef
  2. Nelson HD, Humphrey LL, Nygren P, et al. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;288:872-1 CrossRef
  3. Jourdain O, Avril A, Mauriac L, et al. Breast cancer and in vitro fertilization. About 32 cases. Eur J Obstet Gynecol Reprod Biol 1996;67:47-2 CrossRef
  4. Brinton LA, Melton LJ 3rd, Malkasian GD Jr, et al. Cancer risk after evaluation for infertility. Am J Epidemiol 1989;129:712-2
  5. Gammon MD, Thompson WD. Infertility and breast cancer: a population-based case-control study. Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 1990;132:708-6
  6. Braga C, Negri E, La Vecchia C, et al. Fertility treatment and risk of breast cancer. Hum Reprod 1996;11:300-
  7. Rossing MA, Daling JR, Weiss NS, et al. Risk of breast cancer in a cohort in infertile women. Gynecol Oncol 1996;60:3- CrossRef
  8. Venn A, Watson L, Lumley J, et al. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 1995;346:995-000 CrossRef
  9. Ricci E, Parazzini F, Negri E, et al. Fertility drugs and the risk of breast cancer. Hum Reprod 1999;14:1653- CrossRef
  10. Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilization. Lancet 1999;354:1586-0 CrossRef
  11. Potashnik G, Lerner-Geva L, Genkin L, et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999;71:853- CrossRef
  12. Doyle P, Maconochie N, Beral V, et al. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 2002;17:2209-3 CrossRef
  13. Dor J, Lerner-Geva L, Rabinovici J, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324- CrossRef
  14. Lerner-Geva L, Geva E, Lessing JB, et al. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer 2003;13:23- CrossRef
  15. Gauthier E, Paoletti X, Clavel-Chapelon F; E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 2004;19:2216-1 CrossRef
  16. Bernstein L, Hanisch R, Sullivan-Halley J, et al. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1995;4:437-0
  17. Modan B, Ron E, Lerner-Geva L, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038-2
  18. Brzezinski A, Peretz T, Mor-Yosef S, et al. Ovarian stimulation and breast cancer: Is there a link? Gynecol Oncol 1994;52:292- CrossRef
  19. Brinton LA, Scoccia B, Moghissi KS, et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004;19:2005-3 CrossRef
  20. Burkman RT, Tang MT, Malone KE, et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study. Fertil Steril 2003;79:844-1 CrossRef
  21. Lerner-Geva L, Keinan-Boker L, Blumstein T, et al. Infertility, ovulation induction treatments and the incidence of breast cancer-a historical prospective cohort of Israeli women. Breast Cancer Res Treat 2006;100:201-2 CrossRef
  22. Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod Update 2002;8:265-7 CrossRef
  23. Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991;56:192-
  24. Insler V, Gonnen O, Levran D, et al. Israel National Registry of assisted reproductive technologies. Assisted reproductive technologies reported in the National Registry of Israel 1995-996. Harefuah 2000;139:421-, 495
  25. Israel National Cancer Registry. Annual report updated 1.2005. Israeli Ministry of Health. Available: http://www.health.gov.il/
  26. Fishler Y, Chetrit A, Barchana M, et al. The completeness of the National Cancer Registry database. Methods and results. Completeness of the data in the year 1991 and its implications on the completeness of current data. Israel Center for Disease Control, Oct 2003; publication # 230 [Hebrew]
  27. Rothman KJ, Boice JD, Jr. Epidemiologic analysis with a programmable calculator. Washington, DC: US GPO, 1979. (DHEW publication no. [NIH] 79-1649)
  28. Sellers TA, Potter JD, Severson RK, Bostick RM, Nelson CL, Kushi LH, Folsom AR. Difficulty becoming pregnant and family history as interactive risk factors for postmenopausal breast cancer: the Iowa Women’s Health Study. Cancer Causes Control 1993;4:21- CrossRef
  29. Weiss HA, Troisi R, Rossing MA, et al. Fertility problems and breast cancer risk in young women: a case-control study in the United States. Cancer Causes Control 1998;9:331- CrossRef
  30. Wild S, Pierpoint T, Jacobs H, et al. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 2000;3:101- CrossRef
  31. Ron E, Auvinen A, Alfandary E, et al. Cancer risk following radiotherapy for infertility or menstrual disorders. Int J Cancer 1999;82:795- CrossRef
  32. Klip H, Burger CW, Kenemans P, et al. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 2000;11:319-4 CrossRef
  33. Venn A, Healy D, McLachlan R. Cancer risks associated with the diagnosis of infertility. Best Pract Res Clin Obstet Gynaecol 2003;17:343-7 CrossRef
  34. Cowan LD, Gordis L, Tonascia JA, et al. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 1981;114:209-7
  35. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-
  36. Garland M. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 1998;147:636-3
  37. Liu Q, Wuu J, Lambe M, et al. Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 2002;13:299-05 CrossRef
  38. Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer: Does the association vary by a woman’s predicted breast cancer risk? J Clin Oncol 2006;24:1823-0 CrossRef
  39. Pappo I, Karni T, Sandbank J, et al. Breast cancer in the elderly: histological, hormonal and surgical characteristics. Breast 2007;16:60- CrossRef
  
• 作者单位：I. Pappo MD (1) (2)
  L. Lerner-Geva MD PhD (3)
  A. Halevy MD (2)
  L. Olmer MSc (4)
  S. Friedler MD (5)
  A. Raziel MD (5)
  M. Schachter MD (5)
  R. Ron-El MD (5)
  
  1. Comprehensive Breast Care Institute, Assaf Harofeh Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Israel, Zerifin, 70300, Israel
  2. Division of Surgery, Assaf Harofeh Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Israel, Zerifin, 70300, Israel
  3. Women and Children’s Health Research Unit, Gertner Institute for Epidemiology and Health Policy Research, Tel Hashomer, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel Hashomer, Israel
  4. Biostatistics Unit, Gertner Institute for Epidemiology and Health Policy Research, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Israel, Tel Hashomer, Israel
  5. IVF and Infertility Unit, Assaf Harofeh Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Israel, Zerifin, 70300, Israel
  

文摘

Background The possible association between ovulation-inducing drugs and breast cancer development has been debated. Our aim was to evaluate the incidence of breast cancer in a cohort of women exposed to in vitro fertilization (IVF). Methods A retrospective cohort analysis was performed by linkage of the computerized database of all women treated at the IVF Unit at Assaf Harofeh Medical Center between 1986 and 2003, and the Israeli National Cancer Registry. The standardized incidence ratio (SIR) was computed as the ratio between the observed number of breast cancer cases and the expected cases, adjusted for age and continent of birth, in the general population. Tumor characteristics of the IVF patients were studied by reviewing original medical records. Results 35 breast carcinomas were diagnosed among 3,375 IVF-treated women, compared to 24.8 cases expected (SIR = 1.4; 95% CI 0.98-.96). Age ?0 years at IVF treatment (SIR = 1.9; 95% CI 0.97-.30), hormonal infertility (SIR = 3.1; 95% CI 0.99-.22), and ? IVF cycles (SIR = 2.0; 95% CI 1.15-.27) were found to be risk factors to develop breast cancer compared to the general population. Multivariate analysis revealed that women who underwent ? IVF cycles compared to those with one to three cycles were at risk to develop breast cancer, although not significantly (SIR = 1.9; 95% CI 0.95-.81). Of IVF-treated women 85% had ER(+) tumors and 29% had positive family history. Conclusions A possible association between IVF therapy and breast cancer development was demonstrated, especially in women ?0 years of age. These preliminary findings need to be replicated in other cohort studies.